Experts from Inside India’s IP Market: a Guide 2025 discuss the rapidly evolving AI landscape and outline essential changes ...
Canon India, led by CEO Toshiaki Nomura, aims to be the fastest-growing sales company in the Canon Group by leveraging ...
The Nippon India Pharma Fund - Growth has an AUM of 7637.04 crores & has delivered CAGR of 27.43% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.82%. The minimum ...
The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export market, highlighting India's key role in providing affordable generic ...
AI generated image India's pharma sector has emerged as a big winner amid Trump’s tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs, recognizing the vital role of India ...
The US market accounts for 30% of overall exports for India’s pharma sector. The industry welcomed the decision, saying that it underscores the critical role of cost-effective, life-saving generic ...
US president Donald Trump exempted imports of pharmaceuticals, energy and certain minerals in his “reciprocal tariffs” on Thursday, likely providing reprieve to India’s generic medicines industry.
1. Current NAV: The Current Net Asset Value of the Nippon India Pharma Fund as of Apr 04, 2025 is Rs 109.27 for IDCW option of its Regular plan. 2. Returns: Its trailing returns over different time ...
Dr. Reddy’s Laboratories Ltd., Sun Pharma Ltd. Reciprocal tariffs for more than 60 countries, including India, the European Union, China, Vietnam, among others were announced by Trump.
As every pharma company invests in digital technology ... we are overlooking the potential of such techniques for internal training. The way in which we communicate has changed radically over ...
Ashish Rishi discusses the benefits of synchronous online learning for pharma, providing some tips on how to ensure the ROI on training is measurable. In our increasingly global marketplace ...
Currently, too, the US does not impose any tariff on pharma product imports from India. The US is India’s largest export market for pharmaceutical goods, so the exemption brings huge relief to ...